Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To the Editor, We read with interest the study by Panozzo et al. evaluating early peripheral-blood chimeric antigen receptor (CAR) T-cell expansion as an on-treatment biomarker in patients with relapsed/refractory large B-cell lymphoma treated with axicabtagene ciloleucel.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.